Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADCT


Fundamental

Company: Adc Therapeutics SA
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Exchange: NYSE
Index: RUT
P/E: -
EPS (ttm): -1.45
Insider Own: 18.60%
Shs Outstand: 112.63M
Perf Week: -1.11%
Market Cap: 496.13M
Forward P/E: -
EPS next Y: -1.11
Insider Trans: 0.00%
Shs Float: 100.84M
Perf Month: -3.03%
Enterprise Value: 718.83M
PEG: -
EPS next Q: -0.29
Inst Own: 52.66%
Short Float: 6.43%
Perf Quarter: 29.19%
Income: -166.94M
P/S: 6.60
EPS this Y: 12.76%
Inst Trans: 5.09%
Short Ratio: 7.44
Perf Half Y: 103.30%
Sales: 75.21M
P/B: -
EPS next Y Percentage: 21.46%
ROA: -52.26%
Short Interest: 6.48M
Perf YTD: 101.26%
Book/sh: -2.11
P/C: 2.11
EPS next 5Y: 21.36%
ROE: -
52W High: 4.80 -16.56%
Perf Year: 67.57%
Cash/sh: 1.89
P/FCF: -
EPS past 3/5Y: 18.47% 1.38%
ROIC: -76.47%
52W Low: 1.05 281.43%
Perf 3Y: -3.73%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 27.82% 97.79%
Gross Margin: 89.33%
Volatility W: 5.90%
Volatility M: 6.62%
Perf 5Y: -88.21%
Dividend TTM: -
EV/Sales: 9.56
EPS Y/Y TTM: 39.57%
Oper. Margin: -162.94%
ATR (14): 0.27
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 4.34
Sales Y/Y TTM: 6.35%
Profit Margin: -221.97%
RSI (14): 47.21
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 4.63
EPS Q/Q: 28.44%
SMA20: -3.73%
Beta: 1.90
Target Price: 8.00
Payout: -
Debt/Eq: -
Sales Q/Q: -11.03%
SMA50: 0.13%
Rel Volume: 0.55
Prev Close: 4.00
Employees: 265
LT Debt/Eq: -
Earnings: Nov 10 BMO
SMA200: 46.67%
Avg Volume: 871.44K
Price: 4.01
IPO: May 15, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: 17.42% -2.18%
Trades:
Volume: 235,359
Change: 0.13%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z